J&J Cypher Stent Approval Includes Rapamune Label Change Monitoring

Post-marketing commitments for Johnson & Johnson/ Cordis' Cypher sirolimus-eluting stent include close monitoring of labeling changes for Wyeth's sirolimus product Rapamune

More from Archive

More from Pink Sheet